Search - tctmd.com

Displaying 21 - 40 of 41

Sort: Relevancy | Date

Presentation TVT 2019

Substernal Extracardiac Pacing for SHD Procedures (AtaCor Medical)

Presenter: Martin Burke

June 12, 2019

Presentation TVT 2019

Implementing Shared Decision-Making for Structural Heart Therapies

Presenter: Roseanne Palmer

June 12, 2019

Presentation TVT 2019

Keynote Address: The Impact of the CV Team Professionals

Presenter: Elizabeth Perpetua

June 12, 2019

News Conference News TVT 2017

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Shelley Wood

June 19, 2017

News Conference News TVT 2017

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Michael O'Riordan

June 17, 2017

News Conference News TVT 2017

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

Michael O'Riordan

June 16, 2017

Presentation TVT 2017

Lessons From the TVT Registry: Who Are We Treating and What Are the Outcome With MitraClip in US Practice?

Presenter: Saibal Kar, Paul A. Grayburn

June 15, 2017

Presentation TVT 2017

Device Design Features and Findings From EU Clinical Trials

Presenter: Joachim Schofer

June 15, 2017

Presentation TVT 2017

Device Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

Presenter: Axel Linke

June 15, 2017

News Conference News TVT 2016

Teenage TAVR: Should Practice Forge on While Guidelines Grow Up?

Michael O'Riordan

June 20, 2016

News Conference News TVT 2016

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Michael O'Riordan

June 16, 2016

Presentation TVT 2014

A Citizen of the World and Frequent TAVR Proctor

Presenter: Eberhard Grube

June 07, 2014

Presentation TVT 2014

An Interventionalist from London, UK

Presenter: Martyn R. Thomas

June 07, 2014

Presentation TVT 2014

A Surgeon from Dallas, Texas

Presenter: Michael J. Mack

June 07, 2014

Presentation TVT 2014

The Daunting Task of Explaining High TAVR Costs to Practitioners, Hospital Administrators, and Healthcare Systems

Presenter: Larry L. Wood

June 07, 2014

Presentation TVT 2014

Are Reimbursement Patterns Directly Affecting TAVR Clinical Usage in Europe?

Presenter: Nicolo Piazza

June 07, 2014

Presentation TVT 2014

TAVR is not Cost Effective Compared with Surgery (in Most Patients)!

Presenter: A. Pieter Kappetein

June 07, 2014

Presentation TVT 2014

The TAVR Economic Value Proposition The Impact of Valve Costs, Complications, QOL Benefits, and Reimbursement Strategies

Presenter: David J. Cohen

June 07, 2014

Presentation TVT 2013

The Case for the Hybrid OR-Cath Lab

Presenter: Michael Reardon

June 14, 2013

Presentation TVT 2013

Advantages and Design Requirements of a Hybrid Cath Lab/OR for TAVR (and Other Complex) Procedures

Presenter: Mathew Williams

June 13, 2013

Advertisement

Substernal Extracardiac Pacing for SHD Procedures (AtaCor Medical)

Implementing Shared Decision-Making for Structural Heart Therapies

Keynote Address: The Impact of the CV Team Professionals

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

Lessons From the TVT Registry: Who Are We Treating and What Are the Outcome With MitraClip in US Practice?

Device Design Features and Findings From EU Clinical Trials

Device Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

Teenage TAVR: Should Practice Forge on While Guidelines Grow Up?

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

A Citizen of the World and Frequent TAVR Proctor

An Interventionalist from London, UK

A Surgeon from Dallas, Texas

The Daunting Task of Explaining High TAVR Costs to Practitioners, Hospital Administrators, and Healthcare Systems

Are Reimbursement Patterns Directly Affecting TAVR Clinical Usage in Europe?

TAVR is not Cost Effective Compared with Surgery (in Most Patients)!

The TAVR Economic Value Proposition The Impact of Valve Costs, Complications, QOL Benefits, and Reimbursement Strategies

The Case for the Hybrid OR-Cath Lab

Advantages and Design Requirements of a Hybrid Cath Lab/OR for TAVR (and Other Complex) Procedures

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content